Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Apr;75(4):1270–1277. doi: 10.1172/JCI111826

Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.

R A Eisenberg, K Dyer, S Y Craven, C R Fuller, W J Yount
PMCID: PMC425455  PMID: 3872886

Abstract

Anti-Sm antibodies are highly specific markers for the diagnosis of systemic lupus erythematosus (SLE). This specificity suggests that the immunoregulation of these autoantibodies would reflect fundamental immune abnormalities in this disorder. As a clue to this immunoregulation, we have investigated the isotype distribution of anti-Sm antibodies by enzyme-linked immunosorbent assays. We have found that the anti-Sm response is markedly restricted to the IgG1 heavy chain isotype. On the other hand, the light chain distribution reflects that in normal serum, while isoelectric focusing analysis fails to show an oligoclonal pattern. The related specificity, anti-ribonucleoprotein, is also restricted to IgG1, while the SLE-specific antibody anti-double-stranded DNA is mostly IgG1 with a lesser contribution by IgG3. These results suggest that antinuclear antibodies that are strongly associated with SLE are produced by a T cell-dependent response, probably driven by antigen. The immunoregulation of the response to several autoantigens may be quite similar.

Full text

PDF
1270

Images in this article

1274Image
on p.1274

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aalberse R. C., van der Gaag R., van Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol. 1983 Feb;130(2):722–726. [PubMed] [Google Scholar]
  2. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bankhurst A. D., Lambert P. H., Miescher P. A. Studies on the thymic dependence of the immunoglobulin classes of the mouse (38570). Proc Soc Exp Biol Med. 1975 Feb;148(2):501–504. doi: 10.3181/00379727-148-38570. [DOI] [PubMed] [Google Scholar]
  4. Carson D. A., Lawrance S. Light chain heterogeneity of 19S and 7S anti-gamma-globulins in rheumatoid arthritis and subacute bacterial endocarditis. Arthritis Rheum. 1978 May;21(4):438–440. doi: 10.1002/art.1780210406. [DOI] [PubMed] [Google Scholar]
  5. Cohen P. L., Eisenberg R. A. Anti-Sm autoantibodies in MRL mice: in vitro detection and generation of antibody-forming cells. J Immunol. 1982 Dec;129(6):2682–2685. [PubMed] [Google Scholar]
  6. Cohen P. L., Eisenberg R. A. T cell recognition of the Sm nuclear antigen: induction of T cell proliferative responses in MRL/Mp- +/+ mice. J Immunol. 1982 Nov;129(5):2142–2145. [PubMed] [Google Scholar]
  7. Eisenberg R. A., Klapper D. G., Cohen P. L. The polypeptide structure of the Sm and RNP nuclear antigens. Mol Immunol. 1983 Feb;20(2):187–195. doi: 10.1016/0161-5890(83)90130-x. [DOI] [PubMed] [Google Scholar]
  8. Eisenberg R. A., Tan E. M., Dixon F. J. Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med. 1978 Feb 1;147(2):582–587. doi: 10.1084/jem.147.2.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Eisenberg R. A., Winfield J. B., Cohen P. L. Subclass restriction of anti-Sm antibodies in MRL mice. J Immunol. 1982 Nov;129(5):2146–2149. [PubMed] [Google Scholar]
  10. Eisenberg R., Fox A., Greenblatt J. J., Anderle S. K., Cromartie W. J., Schwab J. H. Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats. Infect Immun. 1982 Oct;38(1):127–135. doi: 10.1128/iai.38.1.127-135.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fisher D. E., Conner G. E., Reeves W. H., Blobel G., Kunkel H. G. Synthesis and assembly of human small nuclear ribonucleoproteins generated by cell-free translation. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6356–6360. doi: 10.1073/pnas.80.20.6356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Freijd A., Hammarström L., Persson M. A., Smith C. I. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin Exp Immunol. 1984 May;56(2):233–238. [PMC free article] [PubMed] [Google Scholar]
  13. Gleichmann E., Van Elven E. H., Van der Veen J. P. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol. 1982 Feb;12(2):152–159. doi: 10.1002/eji.1830120210. [DOI] [PubMed] [Google Scholar]
  14. Hoch S., Schur P. H., Schwaber J. Frequency of anti-DNA antibody producing cells from normals and patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1983 Apr;27(1):28–37. doi: 10.1016/0090-1229(83)90053-3. [DOI] [PubMed] [Google Scholar]
  15. Hultin M. B., London F. S., Shapiro S. S., Yount W. J. Heterogeneity of factor VIII antibodies: further immunochemical and biologic studies. Blood. 1977 May;49(5):807–817. [PubMed] [Google Scholar]
  16. Izui S., Eisenberg R. A., Dixon F. J. Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipopolysaccharides. J Exp Med. 1981 Feb 1;153(2):324–338. doi: 10.1084/jem.153.2.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kacaki J. N., Callerame M. L., Blomgren S. E., Vaughan J. H. Immunoglobulin G subclasses of antinuclear antibodies and renal deposits. Comparison of systemic lupus erythematosus, drug-induced lupus and rheumatoid arthritis. Arthritis Rheum. 1971 Mar-Apr;14(2):276–282. doi: 10.1002/art.1780140214. [DOI] [PubMed] [Google Scholar]
  18. Koffler D., Schur P. H., Kunkel H. G. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med. 1967 Oct 1;126(4):607–624. doi: 10.1084/jem.126.4.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lefvert A. K., Bergström K. Immunoglobulins in myasthenia gravis: effect of human lymph IgG 3 and F (ab')2 fragments on a cholinergic receptor preparation from Torpedo marmorata. Eur J Clin Invest. 1977 Apr;7(2):115–119. doi: 10.1111/j.1365-2362.1977.tb01582.x. [DOI] [PubMed] [Google Scholar]
  20. Lerner M. R., Steitz J. A. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5495–5499. doi: 10.1073/pnas.76.11.5495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lowe J., Bird P., Hardie D., Jefferis R., Ling N. R. Monoclonal antibodies (McAbs) to determinants on human gamma chains: properties of antibodies showing subclass restriction or subclass specificity. Immunology. 1982 Oct;47(2):329–336. [PMC free article] [PubMed] [Google Scholar]
  22. Merrett J., Barnetson R. S., Burr M. L., Merrett T. G. Total and specific IgG4 antibody levels in atopic eczema. Clin Exp Immunol. 1984 Jun;56(3):645–652. [PMC free article] [PubMed] [Google Scholar]
  23. Mongini P. K., Stein K. E., Paul W. E. T cell regulation of IgG subclass antibody production in response to T-independent antigens. J Exp Med. 1981 Jan 1;153(1):1–12. doi: 10.1084/jem.153.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Notman D. D., Kurata N., Tan E. M. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med. 1975 Oct;83(4):464–469. doi: 10.7326/0003-4819-83-4-464. [DOI] [PubMed] [Google Scholar]
  25. Pike I. M., Yount W. J., Puritz E. M., Roberts H. R. Immunochemical characterization of a monoclonal G4,lambda human antibody to factor IX. Blood. 1972 Jul;40(1):1–10. [PubMed] [Google Scholar]
  26. Puritz E. M., Thompson J. A., Jr, Dierberg F., Kraus S. J., Yount W. J. IgG subclasses of fluorescent treponemal antibodies: correlation with complement fixation and clinical stage. Clin Immunol Immunopathol. 1975 Sep;4(3):352–361. doi: 10.1016/0090-1229(75)90004-5. [DOI] [PubMed] [Google Scholar]
  27. Puritz E. M., Yount W. J., Newell M., Utsinger P. D. Immunoglobulin classes and IgG subclasses of human antinuclear antibodies. A correlation of complement fixation and the nephritis of systemic lupus erythematosus. Clin Immunol Immunopathol. 1973 Nov;2(1):98–113. doi: 10.1016/0090-1229(73)90040-8. [DOI] [PubMed] [Google Scholar]
  28. Raum D., Awdeh Z., Glass D., Kammer G., Khan M. A., Coblyn J. S., Weinblatt M., Holdsworth D., Strong L., Rossen R. D. Extended haplotypes of chromosome 6 in adult rheumatoid arthritis. Arthritis Rheum. 1984 May;27(5):516–521. doi: 10.1002/art.1780270506. [DOI] [PubMed] [Google Scholar]
  29. Sabharwal U. K., Fong S., Hoch S., Cook R. D., Vaughan J. H., Curd J. G. Complement activation by antibodies to Sm in systemic lupus erythematosus. Clin Exp Immunol. 1983 Feb;51(2):317–324. [PMC free article] [PubMed] [Google Scholar]
  30. Schur P. H. Human gamma-g subclasses. Prog Clin Immunol. 1972;1:71–104. [PubMed] [Google Scholar]
  31. Schur P. H., Monroe M., Rothfield N. The gammaG subclass of antinuclear and antinucleic acid antibodies. Arthritis Rheum. 1972 Mar-Apr;15(2):174–182. doi: 10.1002/art.1780150206. [DOI] [PubMed] [Google Scholar]
  32. Sharp G. C., Irvin W. S., May C. M., Holman H. R., McDuffie F. C., Hess E. V., Schmid F. R. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med. 1976 Nov 18;295(21):1149–1154. doi: 10.1056/NEJM197611182952101. [DOI] [PubMed] [Google Scholar]
  33. Simmons J. G., Fuller C. R., Buchanan P. D., Yount W. J. Distribution of surface, cytoplasmic and secreted IgG subclasses in human lymphoblastoid cell lines and normal peripheral blood lymphocytes. Scand J Immunol. 1981 Jul;14(1):1–13. doi: 10.1111/j.1365-3083.1981.tb00178.x. [DOI] [PubMed] [Google Scholar]
  34. Slack J. H., Davie J. M. Subclass restriction of murine antibodies. V. The IgG plaque-forming cell response to thymus-independent and thymus-dependent antigens in athymic and euthymic mice. Cell Immunol. 1982 Mar 15;68(1):139–145. doi: 10.1016/0008-8749(82)90096-x. [DOI] [PubMed] [Google Scholar]
  35. Slack J., Der-Balian G. P., Nahm M., Davie J. M. Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J Exp Med. 1980 Apr 1;151(4):853–862. doi: 10.1084/jem.151.4.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sontheimer R. D., Gilliam J. N. DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis. Clin Immunol Immunopathol. 1978 Aug;10(4):459–467. doi: 10.1016/0090-1229(78)90158-7. [DOI] [PubMed] [Google Scholar]
  37. Spiegelberg H. L., Weigle W. O. The production of antisera to human gammaGlobulin subclasses in rabbits using immunological unresponsiveness. J Immunol. 1968 Aug;101(2):377–380. [PubMed] [Google Scholar]
  38. Steinberg A. D., Roths J. B., Murphy E. D., Steinberg R. T., Raveche E. S. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol. 1980 Aug;125(2):871–873. [PubMed] [Google Scholar]
  39. Stevens R., Dichek D., Keld B., Heiner D. IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. J Clin Immunol. 1983 Jan;3(1):65–69. doi: 10.1007/BF00919140. [DOI] [PubMed] [Google Scholar]
  40. Swaak A. J., Groenwold J., Aarden L. A., Feltkamp T. E. Detection of anti-dsDNA as diagnostic tool. Ann Rheum Dis. 1981 Feb;40(1):45–49. doi: 10.1136/ard.40.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Takano M., Golden S. S., Sharp G. C., Agris P. F. Molecular relationships between two nuclear antigens, ribonucleoprotein and Sm: purification of active antigens and their biochemical characterization. Biochemistry. 1981 Oct 13;20(21):5929–5936. doi: 10.1021/bi00524a001. [DOI] [PubMed] [Google Scholar]
  42. Tan E. M., Kunkel H. G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol. 1966 Mar;96(3):464–471. [PubMed] [Google Scholar]
  43. Tojo T., Friou G. J., Spiegelberg H. L. Immunoglobulin G subclass of human antinuclear antibodies. Clin Exp Immunol. 1970 Jan;6(1):145–151. [PMC free article] [PubMed] [Google Scholar]
  44. Yount W. J., Dorner M. M., Kunkel H. G., Kabat E. A. Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med. 1968 Mar 1;127(3):633–646. doi: 10.1084/jem.127.3.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Yount W. J., Seligmann M., Hong R., Good R., Kunkel H. G. Imbalances of gamma globulin subgroups and gene defects in patients with primary hypogammaglobulinemia. J Clin Invest. 1970 Nov;49(11):1957–1966. doi: 10.1172/JCI106415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Zouali M., Jefferis R., Eyquem A. IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases. Immunology. 1984 Mar;51(3):595–600. [PMC free article] [PubMed] [Google Scholar]
  47. van Nieuwkoop J. A., Brand A., Radl J., Skvaril F. Increased levels of IgG4 subclass in 5 patients with acquired respiratory disease. Int Arch Allergy Appl Immunol. 1982;67(1):61–65. doi: 10.1159/000232989. [DOI] [PubMed] [Google Scholar]
  48. van der Giessen M., Homan W. L., van Kernbeek G., Aalberse R. C., Dieges P. H. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy. Int Arch Allergy Appl Immunol. 1976;50(5):625–640. doi: 10.1159/000231566. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES